Contact
searchSearch
HMP Global
Login

September 2017

Feature

Special Article
Clinical Pathways to Address the Challenges of Treatment Resistance and Relapse in Multiple Myeloma
09/19/2017
Executive Summary Multiple myeloma (MM) is caused by abnormal plasma cell growth in bone marrow, resulting in bone destruction, marrow failure, and adverse blood cell production. The course of MM is characterized by...
Executive Summary Multiple myeloma (MM) is caused by abnormal plasma cell growth in bone marrow, resulting in bone destruction, marrow failure, and adverse blood cell production. The course of MM is characterized by...
...
09/19/2017
Journal of Clinical Pathways
Research Reports
The Impact of Decreasing Variability in Surgical Care Through a Structured Multi-Disciplinary Thoracic Oncology Program
09/19/2017
Abstract: In order to identify the impact of decreasing variability in surgical care through a structured multidisciplinary thoracic oncology program (TOP), the researchers observed changes following the...
Abstract: In order to identify the impact of decreasing variability in surgical care through a structured multidisciplinary thoracic oncology program (TOP), the researchers observed changes following the...
...
09/19/2017
Journal of Clinical Pathways
Perspectives
Rationale for the Development of Clinical Pathways and an Overview of the Clinical Pathways Office at the Seattle Cancer Care Alliance
09/19/2017
Abstract: The United States health care system continues moving away from an unsustainable fee-for-service payment model to more novel measures of care delivery. Clinical pathways have emerged as one of the...
Abstract: The United States health care system continues moving away from an unsustainable fee-for-service payment model to more novel measures of care delivery. Clinical pathways have emerged as one of the...
...
09/19/2017
Journal of Clinical Pathways

Column

Clinical Pathways GPS
Clinical Pathways Guiding Where and When
09/19/2017
Clinical pathways most often guide treatment decisions based on a diagnosis, but what about assistance for directing where and when care is most effectively rendered? Improving clinical and financial outcomes...
Clinical pathways most often guide treatment decisions based on a diagnosis, but what about assistance for directing where and when care is most effectively rendered? Improving clinical and financial outcomes...
...
09/19/2017
Journal of Clinical Pathways
Pharma Insights
Are Formulary Exclusion Lists Aligned or Contrary to the Shift to Value-Base Care?
09/19/2017
The use of formulary exclusion lists continues to expand, with clear impacts to the perception and use of all related medications. Annual updates to these lists suggest a need for careful evaluation by benefit...
The use of formulary exclusion lists continues to expand, with clear impacts to the perception and use of all related medications. Annual updates to these lists suggest a need for careful evaluation by benefit...
The...
09/19/2017
Journal of Clinical Pathways
Editor's Page
Moving the Clinical Pathways Conversation Forward
09/18/2017
September brings about many things: the end of summer, the beginning of a new school term, and a march toward the conclusion of another calendar year. For those of us at Journal of Clinical Pathways, September marks...
September brings about many things: the end of summer, the beginning of a new school term, and a march toward the conclusion of another calendar year. For those of us at Journal of Clinical Pathways, September marks...
...
09/18/2017
Journal of Clinical Pathways

Insights

Interview
Personalizing Pathways
09/19/2017
JCP Editors
Seattle Cancer Care Alliance (Seattle, WA) has been a leader in clinical pathways for more than a decade. The treatment center—comprised of clinicians from University of Washington School of Medicine, Fred Hutchinson...
Seattle Cancer Care Alliance (Seattle, WA) has been a leader in clinical pathways for more than a decade. The treatment center—comprised of clinicians from University of Washington School of Medicine, Fred Hutchinson...
...
09/19/2017
Journal of Clinical Pathways
Interview
Financial Navigators to Address Cancer Cost Concerns
09/19/2017
JCP Editors
The passage of the Patient Protection and Affordable Care Act of 2010 (ACA)1 changed the landscape of insurance coverage in the United States. Prior to the ACA’s passage, patients with chronic diseases and...
The passage of the Patient Protection and Affordable Care Act of 2010 (ACA)1 changed the landscape of insurance coverage in the United States. Prior to the ACA’s passage, patients with chronic diseases and...
The...
09/19/2017
Journal of Clinical Pathways

Department

Research in Review
Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine
09/18/2017
JCP Editors
High Risk of Preventable and Mitigable Adverse Events in Cancer Care Researchers have identified a significant burden of adverse events across the cancer care continuum, including preventable or mitigable...
High Risk of Preventable and Mitigable Adverse Events in Cancer Care Researchers have identified a significant burden of adverse events across the cancer care continuum, including preventable or mitigable...
High...
09/18/2017
Journal of Clinical Pathways
JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Volume 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use